Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like ...

The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover ...

The Biden administration is proposing a rule that would require the US government to cover weight-loss drugs, potentially ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

The Centers for Medicare & Medicaid Services is attempting to cover anti-obesity medications under Medicare Part D and ...